
    
      The registry will be conducted prospectively during 2 years in 10 ICUs of l'APHP on behalf on
      the CEDIT. The 10 centers are : (1) ICU of l'hôpital europeén Georges Pompidou, (2) ICU of
      l'Hôpital Louis Mourier, (3) ICU of l'Hôpital de Bicêtre, (4) ICU of GHPS, (5) Respiratory
      ICU of GHPS, (6) ICU of l'Hôpital Lariboisière (7) ICU of l'Hôpital Cochin (8) ICU of
      l'Hôpital Saint-Antoine (9)ICU of l'Hôpital Henri Mondor and (10) ICU of l'Hôpital Tenon.

      The primary outcome will be the number of patients implanted by ECCO2R monthly in each center
      during the 2 years period study.

      Secondary outcomes will be ICU-mortality, invasive ventilation duration, non invasive
      ventilation duration, ICU duration, modalities of ventilation at the ICU discharge,
      hemorragic complications due to the ECCOR device, thrombotic complications due to ECCO2R
      device, intravascular hemolysis due to ECCO2R device, duration of ECCO2R, adjunct therapy to
      ECCO2R and reasons of ECCO2R discontinuation.
    
  